Cite
HARVARD Citation
Lee, S. et al. (2022). Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease. Inflammatory bowel diseases. 28 (2), pp. 309-313. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, S. et al. (2022). Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease. Inflammatory bowel diseases. 28 (2), pp. 309-313. [Online].